Ken Fisher's UTHR Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 23,580 shares of United Therapeutics Corporation (UTHR) worth $9.89 M, representing 0.00% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in UTHR, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2024, adding 10,034 shares. Largest reduction occurred in Q3 2023, reducing 730 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's United Therapeutics Corporation (UTHR) Holding Value Over Time
Track share changes against reported price movement
Quarterly United Therapeutics Corporation (UTHR) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +2,450 | New Buy | 2,450 | $172.24 |
| Q3 2015 | +468 | Add 19.10% | 2,918 | $131.25 |
| Q4 2015 | +219 | Add 7.51% | 3,137 | $156.52 |
| Q1 2016 | -45 | Reduce 1.43% | 3,092 | $115.46 |
| Q3 2016 | +32 | Add 1.03% | 3,124 | $118.12 |
| Q2 2017 | +45 | Add 1.44% | 3,169 | $129.69 |
| Q3 2017 | -520 | Reduce 16.41% | 2,649 | $117.03 |
| Q1 2018 | -2,649 | Sold Out | 2,649 | $0.00 |
| Q4 2022 | +4,419 | New Buy | 4,419 | $278.12 |
| Q1 2023 | -93 | Reduce 2.10% | 4,326 | $223.96 |
| Q2 2023 | +23 | Add 0.53% | 4,349 | $220.75 |
| Q3 2023 | -730 | Reduce 16.79% | 3,619 | $225.87 |
| Q4 2023 | +209 | Add 5.78% | 3,828 | $219.94 |
| Q1 2024 | +993 | Add 25.94% | 4,821 | $229.76 |
| Q2 2024 | +334 | Add 6.93% | 5,155 | $318.61 |
| Q3 2024 | +1,150 | Add 22.31% | 6,305 | $358.35 |
| Q4 2024 | +10,034 | Add 159.14% | 16,339 | $352.85 |
| Q1 2025 | +2,250 | Add 13.77% | 18,589 | $308.28 |
| Q2 2025 | +4 | Add 0.02% | 18,593 | $287.35 |
| Q3 2025 | +4,987 | Add 26.82% | 23,580 | $419.22 |
Ken Fisher's United Therapeutics Corporation Investment FAQs
Ken Fisher first purchased United Therapeutics Corporation (UTHR) in Q1 2015, acquiring 2,450 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held United Therapeutics Corporation (UTHR) for 43 quarters since Q1 2015.
Ken Fisher's largest addition to United Therapeutics Corporation (UTHR) was in Q4 2024, adding 16,339 shares worth $5.77 M.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 23,580 shares of United Therapeutics Corporation (UTHR), valued at approximately $9.89 M.
As of the Q3 2025 filing, United Therapeutics Corporation (UTHR) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in United Therapeutics Corporation (UTHR) was 23,580 shares, as reported at the end of Q3 2025.